Apellis Pharmaceuticals buy phonebroker
Start price
18.01.18
/
50%
€17.99
Target price
22.01.18
€18.94
Performance (%)
6.26%
End price
22.01.18
€19.11
Summary
This prediction ended on 22.01.18 with a price of €19.11. With a performance of 6.26%, the BUY prediction by phonebroker for Apellis Pharmaceuticals closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% | 72.985% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% | 115.777% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% | 49.561% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% | 69.577% |
Comments by phonebroker for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Ein Zock
(Zielkurs erreicht)


